Imagine a world where flickering lights and sounds could slow down the relentless march of Alzheimer's disease. It might sound like a far-fetched idea, but that's exactly what Dr. Annabelle Singer, an associate professor and biomedical engineer, is determined to find out.
In her innovative lab at the Georgia Institute of Technology and Emory University, Dr. Singer is on a mission to understand the intricate patterns of neural activity in the brain and how they go awry in Alzheimer's patients. Her goal? To develop groundbreaking new treatments for this devastating disease.
"We're taking a unique approach to Alzheimer's research," she explains. "We've identified how essential neural activity for memory fails in Alzheimer's, and we're using that knowledge to create brain stimulation techniques that could improve brain health."
While pharmaceutical companies pour billions into drug therapies, Dr. Singer has embarked on a different path. Her tool of choice? A pair of modified ski goggles and headphones.
These seemingly simple devices deliver flickering lights and fast-clicking beeping sounds, all in an effort to decode memory in Alzheimer's patients. It's a non-invasive sensory stimulation technique that has shown promising results in preclinical and feasibility studies.
"The preliminary tests suggest that flickering lights and sound at 40 Hz for an hour a day could potentially slow cognitive decline and preserve vital brain regions for memory," Dr. Singer reveals. "It's an exciting prospect."
But here's where it gets controversial... Dr. Singer has long been skeptical of the potential side effects and limited efficacy of Alzheimer's medications. She believes there must be a better way.
"Most Alzheimer's research focuses on the molecular level, studying protein accumulation and dysfunction," she explains. "We're asking a different question: How do neurons behave electrically to generate memory, and how do these patterns change in Alzheimer's patients?"
Currently, a Phase 3 double-blind clinical trial is underway, involving nearly 700 patients across 70 locations in the United States. The study is led by Cognito Therapeutics, a medtech company specializing in wearable devices, with Dr. Singer serving as a scientific advisor.
"Our hope is that this stimulation will slow or even halt cognitive decline in those who receive it," Dr. Singer says. "The clinical trial should give us the answers we need later this year."
With over 7 million Americans aged 65 and older living with Alzheimer's, and that number expected to nearly double by 2060, the need for effective treatments is urgent. Worldwide, some 57 million people suffer from dementia, with Alzheimer's being the most common form, according to the World Health Organization.
In recent years, the US FDA has fast-tracked the approval of new medications, lecanemab and donanemab, but these treatments come with their own set of risks, including life-threatening swelling or bleeding in the brain. The high cost of these therapies, around $30,000 per year, also limits their accessibility.
Dr. Singer's research offers a potential alternative. Her work has already attracted the attention of James Lah, director of the Cognitive Neurology Program at Emory University.
"In our initial proof-of-concept study, we found that flickering lights seemed to have a beneficial effect on patients with mild cognitive impairment," Dr. Lah explains. "Both their spinal fluid tests and electroencephalograms (EEGs) showed interesting changes in electrical connectivity after exposure to the flicker."
This early success laid the foundation for the current Phase 3 trial.
Dr. Singer's journey to this point is an intriguing one. As a teenager, she was drawn to the world of theater, fascinated by the magic of stage lights and sound. Little did she know that her passion would lead her to a career in biomedical engineering.
"In theater, it was about controlling how people perceived the stage," she reflects. "In neuroscience research, it's about creating a controlled experience and measuring the individual's reaction."
Her research builds on established science showing that flickering lights can impact neural activity in visual brain areas. But for Alzheimer's, she had to innovate further.
"We discovered that light and sound together at 40 Hz could reach the hippocampus, a critical brain region for memory," she explains. "It's an exciting development."
And this is the part most people miss... Dr. Singer's work offers a potential solution that is both safe and accessible. The goggles she's developing could provide a low-risk intervention for Alzheimer's patients.
"If we can offer a safe, non-invasive treatment, it changes the game," she says. "It gives hope to the millions affected by this disease."
As the clinical trial progresses, only time will tell if Dr. Singer's research will revolutionize Alzheimer's treatment. But one thing is certain: her innovative approach and passion for helping others have already made a significant impact.
"The whole notion of using external stimulation to modify brain activity is fascinating," Dr. Lah adds. "It's a cool concept, and I'm excited to see where it leads."
So, what do you think? Could flickering lights and sound be the key to unlocking a brighter future for Alzheimer's patients? The world awaits the results of this groundbreaking research.
